← Leaderboards
Huizhou Fan
Univ Of Med/Dent Nj-R W Johnson Med Sch
$3,194,946
Attributed
$3,194,946
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $432.5K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,194,946 · 7
By mechanism
R21$2,096,976 · 5
R33$971,329 · 1
R03$126,641 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsChlamydia InfectionsChlamydiaWomanInfertilityChlamydia TrachomatisMutationAffectIn VivoBacteriaResistancePathogenLactobacillusInfectionAntibioticsInhibitor/AntagonistEnzymesGenesIn VitroPreventAntimicrobialGrantProteinsOrganism
Grant awards (16)
Exploration of SF3 as a Chemical Probe for Chlamydial Biology$235,500
R21 · FY2021 · AI · contact PI
GrgA:a Multifunctional Transcription Factor that Control Chlamydial Gene Expression$237,320
R21 · FY2020 · AI · contact PI
Exploration of SF3 as a Chemical Probe for Chlamydial Biology$195,209
R21 · FY2020 · AI · contact PI
GrgA:a Multifunctional Transcription Factor that Control Chlamydial Gene Expression$198,160
R21 · FY2019 · AI · contact PI
GrgA: Key Regulator of Chlamydial Physiology and potential Antichlamydial Target$193,904
R21 · FY2017 · AI · contact PI
GrgA: Key Regulator of Chlamydial Physiology and potential Antichlamydial Target$219,741
R21 · FY2016 · AI · contact PI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections$303,205
R33 · FY2011 · AI · contact PI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections$19,288
R33 · FY2011 · AI · contact PI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections$321,674
R33 · FY2010 · AI · contact PI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections$327,162
R33 · FY2009 · AI · contact PI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections$196,628
R21 · FY2008 · AI · contact PI
Role of Klotho Ectodomain Release in Suppression of Aging$62,681
R03 · FY2008 · AG · contact PI
Peptide Deformylase Inhibitor LBM415 for Sexually Transmitted Infections$211,331
R21 · FY2007 · AI · contact PI
Role of Klotho Ectodomain Release in Suppression of Aging$63,960
R03 · FY2007 · AG · contact PI
Specific Inhibition of Chlamydia with Hydroxamates$189,808
R21 · FY2006 · AI · contact PI
Specific Inhibition of Chlamydia with Hydroxamates$219,375
R21 · FY2005 · AI